News blog

IXICO

  • BY: Andrew Hore |
  • POSTED: 12/08/2019 |

Neuroscience-focused digital data analysis technology developer IXICO has signed two new biopharmaceutical client contracts worth a total of more than £1m.

An ongoing phase III study has been extended and this will add £900,000 to the contract value.

One study has been discontinued following an interim review of data. It will not affect revenue this year, but contracted revenues of £3.5m were expected up until 2025. 

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Quoted Micro 19 August 2019

Continue reading... | 19/08/2019

Omega Diagnostics

Food intolerance and diagnostics company Omega Diagnostics has delayed its interim results announcement, although it figures appear likely to be in line with expectations. 

Continue reading... | 19/08/2019

Transense Technologies

More good news from Transense Technologies and the share price rose by 9.5p to 70.5p. 

Continue reading... | 13/08/2019

Ironveld

Ironveld has entered into confidentiality agreements with potential purchasers of its mining rights for the high-purity iron, vanadium and titanium project in the Bushveld complex in South Africa. 

Continue reading... | 12/08/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds